2026/07/25 by Francesco Misirocchi, Alice Ballabeni, Maddalena Frapporti +4
Medicine · #Confidence interval #Emergency department #Epilepsy #Epilepsy research and treatment #Modified Rankin Scale #Pharmacological Effects and Toxicity Studies #Psychosomatic Disorders and Their Treatments #Status epilepticus
paper · doi:10.1002/epi.70414
published in Epilepsia (Wiley)
openalex publication_date 2026/07/25 · openalex created_date 2026/07/26 · openalex updated_date 2026/07/27
Nonconvulsive status epilepticus (NCSE) is difficult to recognize in the emergency department (ED), where onset is often unknown and treatment may be delayed. To what extent treatment timing and dose adequacy are associated with outcome in NCSE remains debated. In this single-center electroencephalography (EEG)-based study, adults with NCSE diagnosed in the ED were included. Timing was measured using ED arrival as a temporal anchor. Outcomes were failure to return to baseline at discharge and in-hospital mortality. Among 74 patients (mean age 66.8), 38 (51.4%) failed to return to baseline and 14 (18.9%) died. ED benzodiazepines (BDZs) were administered in 43 patients (58.1%) and anti-seizure medications (ASMs) in 71 (95.9%). Median times to BDZ and ASM administration were 184 and 223 min, respectively. After adjustment for Status Epilepticus Severity Score (STESS), potentially fatal etiology, and premorbid modified Rankin Scale score, time to ASM (odds ratio [OR]: 1.11 per hour; 95% confidence interval [CI]: 1.01-1.22; p = .037) and ASM underdosing (OR: 3.43; 95% CI: 1.10-10.68; p = .034) were independently associated with failure to return to baseline, with time to BDZ showing a non-significant trend. BDZ underdosing was not associated with functional outcome, and no treatment variable was associated with mortality. These findings support early EEG-based recognition and rapid, adequately dosed ASM treatment as key targets in ED-NCSE management.